To multicenter study to evaluate safety and efficacy of a netupitant and palonosetron-combined drug and to reduce and control post Elipse placement symptoms
Latest Information Update: 03 Jun 2020
At a glance
- Drugs Netupitant/palonosetron (Primary)
- Indications Nausea and vomiting
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 03 Jun 2020 New trial record